{"id":835,"date":"2020-02-17T22:12:48","date_gmt":"2020-02-17T16:42:48","guid":{"rendered":"https:\/\/medicineplexus.com\/?p=835"},"modified":"2020-02-17T22:12:48","modified_gmt":"2020-02-17T16:42:48","slug":"stem-cell-therapy","status":"publish","type":"post","link":"https:\/\/medicineplexus.com\/stem-cell-therapy\/","title":{"rendered":"Stem Cell Therapy"},"content":{"rendered":"\n
Stem Cell Therapy<\/strong><\/p>\n\n\n\n Stem cells <\/strong>are biological cells found in all multicellular organisms, that can divide (through mitosis) and differentiate into diverse specialized cell types and can self-renew to produce more stem cells.<\/p>\n\n\n\n PRIMARY SOURCES OF STEM CELLS<\/strong><\/p>\n\n\n\n I. Embryonic Stem Cells: Derived from very early embryo, <\/em><\/strong>which are isolated from the inner cell mass of blastocysts<\/p>\n\n\n\n II. Fetal Stem Cells: Collected from fetal tissue at a somewhat later stage of development. <\/em> <\/strong><\/p>\n\n\n\n III. Adult Stem Cells: Obtained from mature tissues, differentiate into narrow range of cell types.<\/em><\/strong><\/p>\n\n\n\n Source : Bone marrow, Adipose tissue, which requires extraction by liposuction<\/p>\n\n\n\n The classical definition of a stem cell requires that it possess two properties<\/p>\n\n\n\n Autologous \u2013 Stem Cells<\/strong><\/p>\n\n\n\n Allogeneic \u2013 Stem Cells<\/strong><\/p>\n\n\n\n How stem cell therapy works?<\/em><\/strong><\/p>\n\n\n\n When stem cells are transplanted into the body and arrive into the injured part, brain being targeted for tissue regeneration, the stem cells are coming in contact with growth chemical\u2019s (like EGF\u2019s , NGF\u2019s and HGF\u2019s )in the body. These chemicals program the stem cells to differentitate into the tissue surrounding it.<\/p>\n\n\n\n Uses:<\/strong><\/p>\n\n\n\n Drug Testing<\/strong><\/p>\n\n\n\n Any disease in which there is tissue degeneration can be a potential candidate for stem cell therapies<\/p>\n\n\n\n STEM CELLS IN NEUROLOGY<\/strong><\/p>\n\n\n\n Many nervous system diseases result from loss of nerve cells;<\/p>\n\n\n\n STEM CELLS IN CARDIOLOGY<\/strong><\/p>\n\n\n\n STEM CELLS IN ENDOCRINOLOGY<\/strong><\/p>\n\n\n\n Type I DM<\/strong><\/p>\n\n\n\n STEM CELL THERAPY IN ONCOLOGY<\/strong><\/p>\n\n\n\n Limbal stem Cell therapy<\/strong><\/p>\n\n\n\n Corneal disease \/ blindness<\/u><\/em><\/strong><\/strong><\/p>\n\n\n\n Stem cells in treating baldness<\/u><\/em><\/strong><\/p>\n\n\n\n List of FDA Approved Products<\/strong><\/p>\n\n\n\n 1.HEMACORD (hematopoietic progenitor cells, cord blood) \u2013NYCBB<\/p>\n\n\n\n 2.Autologous Cultured chondrocytes\u2013Carticel<\/strong> \u00e0<\/p>\n\n\n\n \u2013Repair articular cartilage injuries in the knee of adults who had inadequate\/poor response to prior arthroscopic or other surgical repair procedure<\/p>\n\n\n\n \u2013Implanted by a surgical procedure called autologous chondrocyte implantation<\/p>\n\n\n\n 3.Autologous Cellular Immunotherapy—Provenge <\/strong>\u00e0<\/strong><\/p>\n\n\n\n \u2013Autologous cellular immunotherapy for the treatment of asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer<\/p>\n\n\n\n Laviv \u2013Fibrocell Technologies (autologous cultured fibroblasts)<\/p>\n\n\n\n \u2013Only personalized cell therapy approved by the FDA for aesthetic use and was recently approved for the improvement of the appearance of moderate-to-severe \u201csmile line\u201d wrinkles (nasolabial folds)<\/p>\n\n\n\n Gintuit\u2013Allogeneic cultured keratinocytes & fibroblasts in Bovine Collagen<\/p>\n\n\n\n \u2013Allogeneic cellularized scaffold product indicated for topical (non-submerged) application to a surgically created vascular wound bed in the treatment of mucogingival conditions in adults<\/p>\n\n\n\n \u2013used as one application over a surgically created vascular wound bed in the oral cavity<\/p>\n\n\n\n Apligraf<\/strong>-Cell based device-Organogenesis<\/p>\n\n\n\n \u2013<\/p>\n\n\n\n \u2013Indicated for use with standard therapeutic compression for the treatment of non-infected partial and full-thickness skin ulcers due to venous insufficiency <\/strong>of greater than 1 month duration and which have not adequately responded to conventional ulcer therapy<\/p>\n\n\n\n .Dermagraft<\/strong>-cell based device -Advanced Biohealing<\/p>\n\n\n\n \u2013cryopreserved human fibroblast\u2013derived dermal substitute<\/strong>. Made from human cells known as fibroblasts, placed on a dissolvable mesh material<\/strong><\/p>\n\n\n\n \u2013Indicated for full-thickness diabetic foot ulcers <\/strong>that have been present for longer than 6 weeks<\/strong>.<\/p>\n\n\n\n PRIMARY CHALLENGES<\/strong> <\/p>\n\n\n\n ICMR Guidelines<\/strong><\/p>\n\n\n\n
Hematopoietic stem cell transplantation (\u201cHSCT\u201d)<\/u><\/strong><\/p>\n\n\n\n